Related Experiment Video
Updated: Feb 2, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
Dipika R Mohan1,2, Antonio Marcondes Lerario3, Gary D Hammer3,4,5,6
1Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan.
Abstract:
Adrenocortical carcinoma (ACC) is a rare and often fatal cancer, affecting ~1 person per million per year worldwide. Approximately 75% of patients with ACC eventually develop metastases and progress on the few available standard-of-care medical therapies, highlighting an incredible need for an improved understanding of the molecular biology of this disease. Although it has long been known that ACC is characterized by certain histological and genetic features (e.g., high mitotic activity, chromosomal instability, and overexpression of IGF2), only in the last two decades of genomics has the molecular landscape of ACC been more thoroughly characterized. In this review, we describe the findings of historical genetics and recent genomics studies on ACC and discuss how underlying concepts emerging from these studies contribute to the current model of critical pathways for adrenocortical carcinogenesis. Integrative synthesis across these studies reveals that ACC consists of three distinct molecular subtypes with divergent clinical outcomes and implicates differential regulation of Wnt signaling, cell cycle, DNA methylation, immune biology, and steroidogenesis in ACC biology. These cellular programs are pharmacologically targetable and may enable the development of therapeutic strategies to improve outcomes for patients facing this devastating disease.
Insights
Adrenocortical carcinoma (ACC) research reveals three distinct molecular subtypes with different outcomes. Understanding these subtypes and their associated pathways offers new therapeutic targets for this rare cancer.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Adrenocortical carcinoma (ACC) is a rare, aggressive cancer with poor prognosis.
- Limited effective therapies exist, emphasizing the need for deeper molecular understanding.
Purpose of the Study:
- To review historical genetics and recent genomics findings in ACC.
- To integrate these findings into a model of adrenocortical carcinogenesis.
- To identify potential therapeutic targets.
Main Methods:
- Review of historical genetics studies.
- Analysis of recent genomics data.
- Integrative synthesis of molecular findings.
Main Results:
- ACC exhibits three distinct molecular subtypes with varying clinical outcomes.
- Key pathways implicated include Wnt signaling, cell cycle, DNA methylation, immune biology, and steroidogenesis.
- These pathways are pharmacologically targetable.
Conclusions:
- Molecular subtyping provides a framework for understanding ACC heterogeneity.
- Targeting identified cellular programs may lead to novel therapeutic strategies.
- Improved understanding of ACC molecular biology is crucial for developing better treatments.
Related Concept Videos
Genomics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Therapeutic Index
Genome Size and the Evolution of New Genes
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

